成人Still病疾病活动度临床标准制定与验证
基于GIRRCS成人Still病队列187例(开发队列130例、初步验证队列57例)及CONSIDER试验41例外部队列,开发并验证了定义成人Still病疾病活动度的临床标准,以发热、皮疹、关节炎、患者整体评估≥2 cm和CRP>10 mg/L为核心条目。
要点
- 活动性标准:发热+至少1项其他条目,或无发热+至少3项其他条目。
- 低疾病活动度:无发热且前述条目不超过1项。
- 临床无活动性疾病定义为5项标准均不存在。
核心结论
- 开发并验证了成人Still病疾病活动度的临床标准,以支持实现临床无活动性疾病作为主要治疗目标。
研究设计与样本
- 使用GIRRCS成人Still病队列(2022年1月1日至2023年12月31日连续入组,年龄≥18岁且符合Yamaguchi诊断标准,187例)开发并初步验证标准。
- 使用CONSIDER试验基线数据(2012年6月21日至2018年5月5日招募,41例)进行外部验证。
- 条目筛选基于临床特征与医生评估疾病活动度的相关性、主成分分析及以疾病活动度为因变量的纵向线性混合模型。
主要发现
- 选定发热、皮疹、关节炎、患者整体评估至少2 cm、CRP大于10 mg/L作为疾病活动度评估标准。
关键数值与推荐
- 活动性成人Still病:发热且至少一项其他标准(皮疹、关节炎、患者整体评估至少2 cm、CRP大于10 mg/L),或无发热但至少三项其他标准。
- 低疾病活动度:无发热且前述标准不超过一项。
- 临床无活动性疾病:五项标准均不存在。
临床怎么用
- 采用统一临床标准评估成人Still病疾病活动度,以临床无活动性疾病为主要治疗目标。
- 活动性判定需结合发热与皮疹、关节炎、患者整体评估至少2 cm、CRP大于10 mg/L等条目。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of heterogeneous empirical definitions to assess disease activity in adult-onset Still's disease limits evidence on the efficacy of immunosuppressive agents. Thus, we aimed to specifically develop and validate definitions of clinical criteria for the assessment of disease activity in adult-onset Still's disease. METHODS: We used data from the GIRRCS (Gruppo Italiano Di Ricerca in Reumatologia Clinica e Sperimentale) adult-onset Still's disease cohort to develop and validate clinical criteria for disease activity. From Jan 1, 2022, to Dec 31, 2023, consecutive patients attending the Italian rheumatological centres involved in the GIRRCS adult-onset Still's disease were included if they were aged ≥18 years and fulfilled the Yamaguchi criteria for diagnosis of adult-onset Still's disease. Patients' clinical characteristics were assessed at baseline and 3 months and 6 months. Additionally, we used baseline data from the CONSIDER (Canakinumab for treatment of adult-onset Still's disease to achieve reduction of arthritic manifestation) trial to externally validate the criteria (recruitment June 21, 2012, to May 5, 2018). The item reduction was based on correlations between clinical characteristics and disease activity as scored by physicians, principal component analysis, and a longitudinal linear mixed model with disease activity as the dependent variable. Performance of the developed criteria was evaluated using area under the receiver operating characteristic curves (AUROCs), separately for development and validation data. People with lived experience of adult-onset Still's disease were involved in study design and implementation. FINDINGS: 187 patients from GIRRCS (130 [70%] in the development cohort and 57 [30%] in the preliminary validation cohort; 94 [50%] female and 93 [50%] male; mean age 40·8 years [SD 17·3]) and 41 patients from the CONSIDER trial (28 [68%] female and 13 [32%] male; mean age 43·0 years [13·1]) were evaluated. Fever, skin rash, arthritis, patient global assessment of at least 2 cm, and C-reactive protein (CRP) greater than 10 mg/L were selected as the criteria for disease activity assessment. Active adult-onset Still's disease was defined as fever and one of the following criteria: skin rash, arthritis, patient global assessment of at least 2 cm, CRP greater than 10 mg/L; or as no fever but at least three of the other criteria (AUROC of 0·93 in development cohort, 0·85 in the preliminary validation cohort, and 0·88 in the external validation cohort). Patients with no fever and no more than one of the aforementioned criteria were considered to have low disease activity (AUROC of 0·86 at 3 months and 0·94 at 6 months in the preliminary validation cohort). Clinically inactive disease was defined as the absence of all five criteria. INTERPRETATION: Disease activity criteria in adult-onset Still's disease were developed to support the attainment of clinically inactive disease as the main treatment target in patient management. FUNDING: None.
引用
- Ruscitti P, Stamm T, Ritschl V, et al. Development and validation of clinical criteria for the definition of disease activity in adult-onset Still's disease: a cohort study. Lancet Rheumatol. 2026. PMID: 41903559. doi:10.1016/S2665-9913(25)00377-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。